iMieiFarmaci
Store data observed · From public App Store data · How we score apps
- Medical
- App Store
- United States
- —0 ratings
- Paid $8.99
- Updated
- Observed
Ratings
Observed0
Chart position
Observed—Not on the top charts
90-day growth
—not enough history yet
Opportunity score
AI-derived3/100Weak · low confidence
Own iMieiFarmaci? Share your real numbers
Your numbers stay private. They only tune MRRBeam's estimates, so every app's figures get more accurate.
Sign in to share them.
Made iMieiFarmaci? Add a “Tracked in Medical” badge to your site
About iMieiFarmaciObserved
iMieiFarmaci is a Medical app by Andrea Isidori on the United States App Store. Released Jan 29, 2010; last updated May 21, 2026 (version 17.9). iMieiFarmaci costs $8.99 to download.
MRRBeam rates the success of iMieiFarmaci 0/100 (early stage).
iFarmaci è il prontuario di riferimento per iOS e Mac OS. Fornisce informazioni aggiornate su una vasta gamma di farmaci, compresi quelli veterinari. iMieiFarmaci è la versione che include la funzionalità "armadietti" per organizzare i farmaci in tuo possesso e monitorarne la scadenza.
- Success score
- 0/100 Early stage
- In Medical
- Outside the top 100
- Chart position
- Not on the top charts
- Developer
- Andrea Isidori
Loading the full report…
iMieiFarmaci: common questions
- What is iMieiFarmaci?
- iMieiFarmaci is a Medical app developed by Andrea Isidori, available on the App Store. It was first released on Jan 29, 2010.
- How much does iMieiFarmaci cost?
- iMieiFarmaci costs $8.99 to download.
- Is iMieiFarmaci successful?
- MRRBeam rates the success of iMieiFarmaci 0/100 (early stage). The success score combines rating volume, chart position and average rating.
- When was iMieiFarmaci last updated?
- iMieiFarmaci was last updated on May 21, 2026 (version 17.9).
- What are alternatives to iMieiFarmaci?
- Similar Medical apps tracked by MRRBeam include CVS Health, MyChart, healow, UnitedHealthcare and GoodRx: Prescription Savings.
- Is there room to build a competitor to iMieiFarmaci?
- MRRBeam's opportunity score for iMieiFarmaci is 3/100. Limited opening: an older app, little observable demand and low price points.